← All trials
NCT00717730
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2010
- Primary completion
- Sep 1, 2011
- Completion date
- Sep 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 1000
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Sykehuset Innlandet HFLead sponsor
- University of BergenOverall official - principal investigator
- University of BergenSponsor investigator
- Society for Essential Health Action and Training, New Delhi, IndiaCollaborator
- Thrasher Research FundCollaborator
- Society for Essential Health Action and Training, New Delhi, IndiaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.